- Home
- WTBA vs ADCT Comparison
WTBA vs ADCT Comparison
Compare WTBA & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTBA
- ADCT
- Stock Information
- Founded
- WTBA 1893
- ADCT 2011
- Country
- WTBA United States
- ADCT Switzerland
- Employees
- WTBA N/A
- ADCT N/A
- Industry
- WTBA Major Banks
- ADCT Biotechnology: Pharmaceutical Preparations
- Sector
- WTBA Finance
- ADCT Health Care
- Exchange
- WTBA Nasdaq
- ADCT Nasdaq
- Market Cap
- WTBA 331.2M
- ADCT 241.0M
- IPO Year
- WTBA N/A
- ADCT 2020
- Fundamental
- Price
- WTBA $19.69
- ADCT $2.71
- Analyst Decision
- WTBA Hold
- ADCT Strong Buy
- Analyst Count
- WTBA 1
- ADCT 6
- Target Price
- WTBA $23.00
- ADCT $7.80
- AVG Volume (30 Days)
- WTBA 32.8K
- ADCT 1.0M
- Earning Date
- WTBA 07-24-2025
- ADCT 08-05-2025
- Dividend Yield
- WTBA 5.08%
- ADCT N/A
- EPS Growth
- WTBA 15.99
- ADCT N/A
- EPS
- WTBA 1.53
- ADCT N/A
- Revenue
- WTBA $82,845,000.00
- ADCT $75,817,000.00
- Revenue This Year
- WTBA $23.88
- ADCT $10.65
- Revenue Next Year
- WTBA $10.37
- ADCT $15.05
- P/E Ratio
- WTBA $13.00
- ADCT N/A
- Revenue Growth
- WTBA 9.30
- ADCT 10.49
- 52 Week Low
- WTBA $16.36
- ADCT $1.05
- 52 Week High
- WTBA $24.85
- ADCT $4.13
- Technical
- Relative Strength Index (RSI)
- WTBA 50.91
- ADCT 46.56
- Support Level
- WTBA $18.51
- ADCT $2.59
- Resistance Level
- WTBA $19.71
- ADCT $2.98
- Average True Range (ATR)
- WTBA 0.43
- ADCT 0.31
- MACD
- WTBA 0.03
- ADCT -0.15
- Stochastic Oscillator
- WTBA 58.22
- ADCT 8.70
About WTBA West Bancorporation
West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America region.
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).